Company / Capital Expenditures
Prime Medicine, Inc. Capital Expenditures History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$4.5M
FY2025
5-year range
$4.2M / $16.1M
FY2021-FY2025
Trend
-48.1%
vs FY2024
Sector context
#76 of 194
Health Care
What the data says
At $5M, Prime Medicine, Inc.'s capital expenditures ranks #76 of 194 in the Health Care sector. Declined from $9M to $5M over the past 2 years.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of +48.0%.
Declined from $9M to $5M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -34.5%
- 5-Year CAGR
- +48.0%
- 10-Year CAGR
- -
Sector benchmark
#76 of 194 in Health CareTop 39% of 194This company $4.5M Sector average $117.5M
▼
-96.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +48.0%, indicating consistent growth.
- In FY2025, capital expenditures decreased 48.1% year-over-year.
- Ranks #76 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.5M | -48.1% |
| FY2024 | $8.7M | +0.0% |
| FY2023 | $8.7M | -45.8% |
| FY2022 | $16.1M | +287.8% |
| FY2021 | $4.2M | +549.5% |
| FY2020 | $639.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026